Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

NCT01710644 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Insufficiency
Cystic Fibrosis
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases

Interventions

DRUG: Burlulipase
DRUG: Placebo (Caramel in sterile water)

Sponsor

Nordmark Arzneimittel GmbH & Co. KG

Collaborators

[object Object]